Table M.1Test accuracy statistics used in the health economic model for women with mild or moderate gestational hypertension

TestSensitivity (95% CI)Specificity (95% CI)
PCR (Al et al., 2004)9480% (64% to 91%)74% (66% to 81%)
PCR (Dwyer et al., 2008)9066% (52% to 78%)95% (86% to 99%)
PCR (Leanos-Miranda et al., 2007)9198% (96% to 99%)99% (98% to 99.5%)
PCR (Ramos et al., 1999)9294% (not reported)80% (not reported)
PCR (Wheeler et al., 2007) 9386.8% (not reported)77.6% (not reported)
Automated reagent-strip reading device (Waugh et al., 2005) 8182% (71% to 90%)81% (71% to 88%)

From: Appendix M, Cost effectiveness of quantifying proteinuria in women with gestational hypertension

Cover of Hypertension in Pregnancy
Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy.
NICE Clinical Guidelines, No. 107.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2010 Aug.
Copyright © 2011, Royal College of Obstetricians and Gynaecologists.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK []. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.